华泰柏瑞中证创新药产业ETF(517120)资产配置
序号 |
报告期 |
股票占净比(%) |
债券占净比(%) |
现金占净比(%) |
净资产(元) |
1 |
2025-03-31 |
97.79 |
- |
3.53 |
300,260,633.28 |
2 |
2024-12-31 |
97.01 |
- |
3.11 |
314,573,211.54 |
3 |
2024-09-30 |
98.00 |
- |
2.04 |
348,130,966.62 |
4 |
2024-06-30 |
96.41 |
- |
3.70 |
269,724,046.95 |
5 |
2024-03-31 |
96.50 |
- |
3.82 |
307,912,430.85 |
6 |
2023-12-31 |
97.26 |
- |
2.82 |
383,951,394.26 |
7 |
2023-09-30 |
97.11 |
- |
2.94 |
387,022,623.84 |
8 |
2023-06-30 |
96.86 |
- |
3.74 |
350,489,397.45 |
9 |
2023-03-31 |
96.52 |
- |
3.58 |
346,364,276.01 |
10 |
2022-12-31 |
96.73 |
- |
3.32 |
373,950,354.71 |
11 |
2022-09-30 |
94.47 |
- |
5.97 |
296,417,875.89 |
12 |
2022-06-30 |
96.26 |
- |
3.91 |
351,801,859.89 |
13 |
2022-03-31 |
95.09 |
0.11 |
5.12 |
351,735,668.62 |
14 |
2021-12-31 |
96.38 |
- |
3.76 |
415,043,006.48 |
15 |
2021-09-30 |
96.36 |
- |
3.92 |
437,363,206.72 |